Madryn Asset Management, a holder of approximately 4.2% of the outstanding common stock of SomaLogic (SLGC), issued a presentation detailing why shareholders should reject the company’s proposed merger with Standard BioTools (LAB).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SLGC:
